Mycronic AB (publ)
MICLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.17 | 0.36 | -1.67 | -0.33 |
| FCF Yield | 8.95% | 11.37% | 5.54% | 8.13% |
| EV / EBITDA | 7.08 | 7.59 | 10.65 | 9.31 |
| Quality | ||||
| ROIC | 22.36% | 19.78% | 16.34% | 17.03% |
| Gross Margin | 52.70% | 50.05% | 44.70% | 49.28% |
| Cash Conversion Ratio | 0.90 | – | 0.96 | 0.95 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.30% | 7.18% | 9.66% | 2.48% |
| Free Cash Flow Growth | 23.62% | 98.60% | -21.59% | -8.38% |
| Safety | ||||
| Net Debt / EBITDA | -1.18 | -1.38 | -0.90 | -0.38 |
| Interest Coverage | 134.20 | 92.85 | 68.77 | 71.21 |
| Efficiency | ||||
| Inventory Turnover | 1.62 | 1.78 | 1.98 | 1.72 |
| Cash Conversion Cycle | 252.15 | 238.83 | 246.54 | 239.28 |